Ellen Relkin is an associate attorney at the New York City based personal injury law firm of Weitz & Luxenberg.
Ms. Relkin, whose practice focuses on medical device and pharmaceutical product liability, as well as toxic tort matters, has represented thousands of plaintiffs injured by defective medical products with a recent focus on the generation of failed metal-on-metal and modular hip implants.
She serves in leadership capacities appointed by courts as the Co-Lead Counsel of the In Re: DePuy ASR Multi-District Litigation (MDL) and the Lead and Liaison Counsel for the New Jersey In Re: Stryker Rejuvenate & ABG II Modular Hip Implant Litigation as well as a member of the Plaintiff Steering Committee in the In Re: Xarelto Product Liability Litigation and the Executive Committee of In Re: Invokana (Canagliflozin) Products Liability Litigation.
She had served on the court-appointed Executive Committee of the MDL involving the birth control patch Ortho Evra, and as the Plaintiffs’ Liaison counsel in the New Jersey consolidated litigation involving the oral contraceptives Yaz, Yasmin and Ocella, as well as on the Court Appointed Plainitffs’ Steering Committee of the In Re: Biomet Hip Implant Litigation.
Notable Court Victories
|Amount||Case||Case Type||Victory Type|
|$2,500,000,000||In re: ASR Hip Implant Products Liability Litigation||Personal Injury; Defective Medical Devices; Product Liability||Settlement|
|$1,000,000,000||In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation||Personal Injury; Defective Medical Devices; Product Liability||Settlement|
|$13,504,045||McDarby, et al. v. Merck & Company||Personal Injury; Defective Drugs; Product Liability||Verdict|
Membership in Court Victories Clubs
Multibillion-Dollar Verdicts & Settlements Club - member since 2017.
Weitz & Luxenberg PC
New York, NY 10003
Phone: (212) 558-5500